Biolidics Limited reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SGD 0.041 million compared to SGD 0.765 million a year ago. Net loss was SGD 0.596 million compared to SGD 0.873 million a year ago. Basic loss per share from continuing operations was SGD 0.0011 compared to SGD 0.0033 a year ago. Diluted loss per share from continuing operations was SGD 0.0011 compared to SGD 0.0033 a year ago.
For the nine months, sales was SGD 1.24 million compared to SGD 1.45 million a year ago. Net loss was SGD 1.55 million compared to SGD 3.16 million a year ago. Basic loss per share from continuing operations was SGD 0.0029 compared to SGD 0.0119 a year ago. Diluted loss per share from continuing operations was SGD 0.0029 compared to SGD 0.0119 a year ago.